Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$244M |
| 2 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$143M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$137M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$109M |
| 5 |
VMW
VMware, Inc
VMW
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Apple
AAPL
|
+$763M |
| 3 |
Microsoft
MSFT
|
+$618M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$592M |
| 5 |
AABA
Altaba Inc
AABA
|
+$393M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.41% |
| 2 | Healthcare | 5.88% |
| 3 | Financials | 5.51% |
| 4 | Consumer Discretionary | 4.79% |
| 5 | Communication Services | 4.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Novartis
NVS
$293B
| $874K | ﹤0.01% |
12,909
-99
| -0.8% | -$6.83K |
|
3377
Arrowhead Research
ARWR
$12.1B
| $873K | ﹤0.01% |
64,152
-66,020
| -51% | -$617K |
|
3378
PUT
Targa Resources
TRGP
$57.6B
| $871K | ﹤0.01% |
17,600
-11,600
| -40% | -$551K |
|
|
TSE
3379
DELISTED
Trinseo
TSE
| $871K | ﹤0.01% |
12,251
-18,971
| -61% | -$1.41M |
|
3380
CALL
TSMC
TSM
$2.17T
| $870K | ﹤0.01% |
23,800
-36,200
| -60% | -$1.43M |
|
3381
CALL
Albemarle
ALB
$14.8B
| $868K | ﹤0.01% |
9,200
+3,600
| +64% | +$346K |
|
3382
Warrior Met Coal
HCC
$4.73B
| $868K | ﹤0.01% |
31,456
-21,224
| -40% | -$559K |
|
|
RDUS
3383
DELISTED
Radius Health, Inc.
RDUS
| $867K | ﹤0.01% |
29,380
+12,042
| +69% | +$380K |
|
3384
Medpace
MEDP
$16.3B
| $866K | ﹤0.01% |
20,160
-30,601
| -60% | -$1.24M |
|
3385
Innospec
IOSP
$2.25B
| $865K | ﹤0.01% |
11,299
+2,727
| +32% | +$204K |
|
|
HZNP
3386
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $864K | ﹤0.01% |
52,200
+2,900
| +6% | +$44.2K |
|
3387
PUT
American Eagle Outfitters
AEO
$2.97B
| $863K | ﹤0.01% |
37,100
-15,000
| -29% | -$333K |
|
3388
PUT
Tenet Healthcare
THC
$20.7B
| $863K | ﹤0.01% |
25,700
-15,200
| -37% | -$473K |
|
|
ARA
3389
DELISTED
American Renal Associates Holdings, Inc
ARA
| $860K | ﹤0.01% |
54,530
+2,235
| +4% | +$35.1K |
|
|
BCS.PRD.CL
3390
DELISTED
Barclays Bank Plc
BCS.PRD.CL
| $859K | ﹤0.01% |
32,500
| – | – |
|
|
XEC
3391
PUT
DELISTED
CIMAREX ENERGY CO
XEC
| $855K | ﹤0.01% |
8,400
-100
| -1% | -$9.5K |
|
3392
Diodes
DIOD
$4.55B
| $854K | ﹤0.01% |
24,744
-3,979
| -14% | -$131K |
|
3393
Greif
GEF
$5.07B
| $854K | ﹤0.01% |
16,166
+1,428
| +10% | +$82.2K |
|
3394
Kemper
KMPR
$1.76B
| $854K | ﹤0.01% |
11,276
-20,492
| -65% | -$1.44M |
|
3395
PUT
Phillips 66
PSX
$82B
| $854K | ﹤0.01% |
7,600
-2,400
| -24% | -$270K |
|
|
BRS
3396
DELISTED
Bristow Group, Inc.
BRS
| $854K | ﹤0.01% |
60,554
-1,113
| -2% | -$16.6K |
|
|
JCP
3397
PUT
DELISTED
J.C. Penney Company, Inc.
JCP
| $852K | ﹤0.01% |
363,900
-147,200
| -29% | -$415K |
|
3398
iShares MSCI ACWI ETF
ACWI
$33.3B
| $850K | ﹤0.01% |
11,948
+4,100
| +52% | +$297K |
|
3399
CALL
Unum
UNM
$14.2B
| $847K | ﹤0.01% |
+22,900
| New | +$955K |
|
|
OCLR
3400
CALL
DELISTED
Oclaro Inc.
OCLR
| $847K | ﹤0.01% |
94,900
-39,900
| -30% | -$349K |
|
Similar funds
Barclays's Q2 2018 Portfolio in Review
As of Q2 2018, Barclays held 7,691 positions worth $116B, down 11% from $131B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays withdrew a net $18.4B in Q2 2018, closing 585 positions and reducing 3,613 holdings. Its most notable exit was Time Warner Inc, an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 8.6% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in Evergy worth $42M.
- Barclays's largest Q2 2018 buy was Evergy: 747,502 shares worth $42M.
- Barclays added most to State Street Industrial Select Sector SPDR ETF in Q2 2018, an estimated $244M increase.
- Barclays's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- Barclays fully exited Time Warner Inc in Q2 2018, selling an estimated $290M.
- Barclays's ten largest holdings make up 27% of its $116B portfolio in Q2 2018.
- Barclays opened 402 new positions and closed 585 in Q2 2018.
- Barclays's portfolio value fell 11% quarter-over-quarter to $116B.
Based on Barclays's 13F filing for Q2 2018, filed 14 Aug 2018.